Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

ibutilide

ibutilide
  • Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Corvert SOLUTION, INTRAVENOUS 0.1 mg/mL      
VIEW MORE Class III Antiarrhythmics
CLASS
24040420
Comments:
  • Patient must be in an ICU or CSSM (if no ICU bed available) for drug administration, and remain in ICU/CSSM for at least 3 hours after administration.  After this time, patient may transfer to PCU
  • EKG monitoring during and for at least 4 hours after administration
  • Physician, CRNP, or PA at bedside during administration
Last updated: Jun. 27, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved